KRAS and acute lymphoblastic leukemia: An exception to this pattern is mutations in KRAS that were instead found expanded in relapse samples.34,36 However, in contrast to infant RAS-mutant KMT2A-rearranged ALL, the presence of these mutations does not impact the outcome of the patients.